prod svg

COMPANY PROFILE

At TLC we specialize in the custom synthesis of complex organic compounds for use as reference standards by the bio-medical and pharmaceutical industries around the world.

UNCOMPROMISED QUALITY
At TLC, quality is not just a commitment, it is ingrained in our culture. Our extensive COA, which includes HPLC, NMR, MS, IR, EA, GC, Water Content, residual solvents and Assay, coupled with ISO 17034 and ISO 17025 accreditations, serves as a testament to our unwavering dedication to delivering products that meet the highest standards of excellence in the industry.
EXTENSIVE INVENTORY
TLC currently offers over 22,000 certified reference standards from stock and we add approximately 2,000 new standards yearly. Our product line includes Active Pharmaceutical Ingredients (API), drug impurities and metabolite standards, as well as their stable isotope labelled analogues and amino acid/peptide drug standards.

2025 2023 News

TLC Named “Company of the Year – Canada 2025” by Pharma Tech Outlook Magazine

We’re proud to share that TLC has been recognized as the Custom Synthesis Organic Compounds Manufacturing Company of the Year – Canada 2025 by Pharma Tech Outlook Magazine.


This honor follows an extensive evaluation by industry experts, C-level executives, and the publication’s editorial board, supported by numerous subscriber nominations highlighting TLC’s reputation, scientific excellence, and consistent performance under pressure.


Featured as the cover story in Pharma Tech Outlook’s Pharma Manufacturing latest issue, the article showcases TLC’s role as a trusted synthesis partner helping pharmaceutical companies navigate complex regulatory and development challenges.


Read the full article:   https://www.pharmatechoutlook.com/tlc-pharmaceutical-standards


Download the full reprint:

2024 NewsJuly 30, 2025

2025 2023 News

CPHI Shanghai 2025

TLC is excited to announce that we will be exhibiting at CPHI 2025 in Shanghai!

Join us at our booth E2C80 from June 24th to 26th, 2025 to explore our latest innovations, meet our team, and discover how we’re driving progress in the healthcare and pharmaceutical industries.

Let’s connect and collaborate!

2024 NewsJanuary 01, 2025

More News...